Foresite Capital Management V, LLC
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 99.3%; sector active share 90.6% against the combined 13F book's sector weights.
Over time 23 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
9 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $362,202,117 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | −692 | 476,386 | $6,693,223 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ODTX | Odyssey Therapeutics, Inc. | 713,105 | $13,342,194 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 25,905 | $773,264 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ALMS |
Alumis Inc.
Healthcare
|
Held | 5,896,995 | $165,941,439 | 45.81% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 1,079,050 | $76,666,502 | 21.17% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 374,069 | $27,359,406 | 7.55% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Held | 738,151 | $25,591,695 | 7.07% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 664,142 | $22,966,030 | 6.34% | |
| EIKN |
Eikon Therapeutics, Inc.
Healthcare
|
Held | 1,318,983 | $17,212,728 | 4.75% | |
| ODTX |
Odyssey Therapeutics, Inc.
Healthcare
|
NEW | 713,105 | $13,342,194 | 3.68% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Reduced | 476,386 | $6,693,223 | 1.85% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Held | 265,000 | $6,428,900 | 1.77% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.